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Aim: To assess the perceived disease burden, awareness
of bacterial pathogens and management of otitis media (OM)
in primary care.
Methods: A cross-sectional survey was conducted among
200 paediatricians in each of Argentina, Mexico, South
Korea, Thailand and Saudi Arabia (n = 1000). Respondents
had been in clinical practice from 5 to 30 years, and pre-
scribe vaccinations for children <5 years. Data are described
as mean and range across the 5 countries.
Results: Physicians reported that approximately 11% of
children (<5 years) consulted for OM in the previous year
and that they saw on average one child per day with OM. Of
these children 57% (range 46—71%) presented with an initial
episode and 34% (range 27—42%) with a recurrent episode.
Overall, 14% (range 10—18%) of children with OM required
referral to a specialist, primarily for treatment failure
(mean 45%, range 31—64%), recurrent disease (mean 39%,
range 10—79%) or hearing problems (mean 32%, range
14—48%). Although 99% respondents reported to be aware
of S. pneumoniae and H. inﬂuenzae as bacterial pathogens,
79% (range 73—87%) knew of non-typable H. inﬂuenzae
(NTHi). Of those who reported to be aware of NTHi, only
59% (range 45-67%) were aware of its role in the aetiol-
ogy of OM. While awareness of antimicrobial resistance was
widespread, physicians tended to use broad spectrum antibi-
otics as initial treatment (mean 91%, range 84-97%) and
few practiced “watchful waiting” (mean 1%, range 0-3%).
Where available, pneumococcal vaccine was reported to be
used to protect children against OM by 42% of physicians in
Argentina, 66% in South Korea and 43% in Mexico.
Conclusion: This multinational survey shows that OM
remains a signiﬁcant burden for clinical practice. Treatment
is largely empirical and antimicrobial therapy remains the
mainstay of treatment for OM. Awareness of the role of NTHi
in OM is limited.
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Correlation of Risk Factors with Colonization of Poten-
tially Pathogenic Oropharyngeal Microﬂora in Infants
D. Nayak ∗, M. Naveen Kumar, N. Bhaskaranand
Kasturba Medical College, Manipal, India
Background: Oropharyngeal colonization is affected by
various factors which modify bacterial growth in growing
infants. Limited epidemiological data is available on the
inﬂuence of factors like introduction of weaning, mixed
feeding, presence of siblings, season of sampling and sex
on the pathogenic microﬂora of oropharynx.
Methods: The present study was conducted on 464 infants
(238 males and 226 females) with or without upper respira-
tory tract infection between 15 days of age to one year,
which included 254 exclusively breast fed and 210 mixed
fed (breast feed and other weaning feeds) infants. Collec-
tion of specimens was performed by oropharyngeal swab
under aseptic precautions using two cotton-tipped appli-
cator sticks, pressed ﬁrmly around Waldeyer’s ring, under
direct visualization and plated over blood agar and choco-
late agar plates. Representative colonies were identiﬁed
using standard microbial procedures.
Results: Symptomatic infants were more in mixed fed
(16.7%) compared to exclusively breast fed infants (9.8%).
Infants of six month age group showed signiﬁcant association
with isolation o potentially pathogenic bacteria (p < 0.05,
with increasing odds ratio). Presence of sibling less than 18
years of age at home also showed signiﬁcant inﬂuence on iso-
lation of pathogenic bacteria (p = 0.005, OR = 2.186).There
was no signiﬁcant seasonal variation in isolation of poten-
tially pathogenic bacteria (p > 0.05). Rate of colonization did
not differ signiﬁcantly in either sex.
Conclusion: Oropharyngeal colonization with pathogenic
bacteria was found to have positive correlation with intro-
duction of weaning and presence of siblings. However no




Ganciclovir Therapy for Symptomatic CMV Infection in the
Newborns
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Background: Evaluation of the safety ganciclovir
(GCV) therapy in newborns with symptomatic congenital
cytomegalovirus (CMV) infection.
Methods: Neonates with symptomatic congenital CMV
infection assigned to receive treatment with intravenous
GCV. During and after GCV treatment complete blood count
was performed. The individual doses of GCV were used and
its blood levels were analyzed with HPLC method.
Results: A total of 57 newborns with a history of
symptomatic congenital CMV infection, hospitalized at
Neonatology Department & NICU between January 2002 and
December 2006, treated with GCV were included in the
study. The mean duration of therapy was 21 (14—34) days.
The mean daily dose of GCV was 12,28± 4,82mg/kg/day.
The GCV (median) serum concentration at 0 h (C max)
after infusion was 6.13 (3,31—8,67) mcg/ml and at 4.5 h
(C 4,5) after the end of GCV infusion was 1.51(0,6—3,04)
mcg/ml respectively. During the GCV treatment the follow-
ing side effects were noted: neutropenia in 19 (33,33%),
anemia in 30 (52,63%), elevated aminotransferase levels
in 8 (14,04%)newborns. No thrombocytopenia was observed
